Ramsey Medical, Inc.

Ramsey Medical, Inc. specializes in portable manual-inflation electronic sphygmomanometers. These devices are designed to measure blood pressure and are intended for use in both clinical environments and home settings. The focus is on providing accurate, real-time readings for monitoring cardiovascular health.

Ramsey Medical, Inc. is headquartered in the United States. The company’s location ensures compliance with U.S. regulatory standards for medical devices, including those governing blood pressure measurement equipment.

Ramsey Medical, Inc.’s devices fall under Class II classification by the FDA. This classification applies to devices that pose moderate risk and require special controls to ensure safety and effectiveness, such as manual-inflation electronic sphygmomanometers. The classification reflects the need for regulatory oversight while allowing streamlined pathways like 510(k) premarket notifications.

Ramsey Medical, Inc.’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) system. These registries ensure transparency and traceability of medical devices, including blood pressure monitors, by assigning unique identifiers and documenting regulatory submissions.

The 510(k) premarket notification process is used for Class II devices like Ramsey Medical’s sphygmomanometers when they are substantially equivalent to a legally marketed predicate device. This pathway demonstrates that the new device has the same intended use, technological characteristics, and safety/effectiveness as an existing authorised device, reducing the need for more rigorous clinical trials.